Jeevan Scientific Technology Ltd Performance
Open
50.85
Traded Value (Cr)
7.30 L
Prev. Close
49.54
VWAP
48.81
Volume
15,114
Face Value
10
Jeevan Scientific Technology Ltd Fundamentals
Jeevan Scientific Technology Ltd Financials
Resistance and Support
₹49.96
PIVOT
Resistance | |
---|---|
First Resistance | ₹51.827 |
Second Resistance | ₹53.813 |
Third Resistance | ₹55.677 |
Support | |
---|---|
First Resistance | ₹47.977 |
Second Resistance | ₹46.113 |
Third Resistance | ₹44.127 |
RSI | 43.042 |
MACD | -0.724 |
ADX | 32.687 |
CCI | -166.199 |
Delivery and Volume
About Jeevan Scientific Technology Ltd
Jeevan Scientific Technology Ltd (Erstwhile Jeevan Softech Limited) was incorporated on 2nd February, 1999 to carry on the business Clinical research, Data Management Services. The Company was promoted by Krishna Kishore Kuchipudi and K Vanaja. The Company is an Independent Clinical Contract Research Organization offering reliable, cost effective and technology-driven clinical research solutions to various clients across the globe. The Company started with an overall focus on Products Development, International and Domestic markets and Training segment. During the year 2000-01,the company had developed and released products for Edible Oil Industry,Engineering Industry,Hospital Management. The company is the member of STPI under 100% Export oriented unit Registration scheme and also achieved Software Exports during 2000-01,to USA based organisation C.S.Consultants Inc. The company has entered into an agreement with the University of Madras as a strudy centre for Hyderabad to provide MCA,M.Sc,MBA through distance education mode by the Jeevan School of Computer Sciences,a division of Jeevan Softech Limited. The company had issued 15,20,000 Equity Shares of Rs.10/- each at par to the public during 2000-01 and consequently the Share Capital of the company has risen to Rs.6.04 crores. In 2011, the Company started Medical Writing Services. It opened Jeevan Scientific New Corporate and Bioanalytical Lab facility in December, 2014. The Clinical Pharmacology Unit with 132 bed capacity opened in Balanagar, Hyderabad in October, 2016. Thereafter, it completed BA/BE studies on 08 June, 2017. In FY 2018-19, the Company acquired nearly 10 LC-MS/MS systems which got launched to accommodate possible work. Thereafter, it started offering clinical research services like Bioavailability/Bioequivalence studies and Phase I to Phase IV services to pharmaceutical and biotechnology industries. In 2021-22, Enhops Solutions Private Limited (ESPL) and Enhops Inc (El), have ceased to be Wholly owned material subsidiaries of the Company.
Managing Director
K Krishna Kishore
Founded
1999
NSE Symbol
Jeevan Scientific Technology Ltd Management
Name | Designation |
---|---|
K Krishna Kishore | Vice Chairman & M.D. |
T Ravi Babu | Non Executive Director |
G Bhanu Prakash | Independent Director |
Koteswara Rao SSR | Chairman & Independent Directo |
Snigdha Mothukuri | Executive Director & CEO |
K. Jeevan Krishna | Executive Director & CFO |
Sharvari Swapnil Shinde | Company Sec. & Compli. Officer |
Nageswar Rao Yarllagadda | Executive Director |
G. Venkata Subba Rao | Independent Director |
Divakar Atluri | Independent Director |
B Suryaprakash Rao | Independent Director |
Jeevan Scientific Technology Ltd News
Similar Stocks
Company | Market Cap | Market Price | P/E Ratio |
---|---|---|---|
APOLLOHOSP | ₹ 83,506 Cr | ₹ 5,834.10 (0.45 %) | 83.62 |
MAXHEALTH | ₹ 77,286 Cr | ₹ 810.00 (1.86 %) | 135.24 |
MEDANTA | ₹ 37,490 Cr | ₹ 1,414.60 (1.31 %) | 107.24 |
FORTIS | ₹ 34,097 Cr | ₹ 441.15 (-2.32 %) | 447.18 |
NH | ₹ 25,403 Cr | ₹ 1,261.70 (1.50 %) | 70.87 |